SPHERE HEALTH Opens Early Access to AI Hormonal Care Platform

Oct 2, 2026
SPHERE HEALTH opened early access to a virtual care platform for women managing hormonal and metabolic conditions. Its Rosalyn system uses AI to organize patient records and prepare information for physician review.

SPHERE HEALTH opened early access to its virtual care platform for women with hormonal and metabolic conditions, the company said in a press release. The service covers conditions and stages including polyendocrine metabolic ovarian syndrome, endometriosis, perimenopause and menopause.

Its Rosalyn platform uses AI to combine a patient's assessment, medical history and laboratory results into one view. It prepares information for review by board certified physicians, who approve care plans and make treatment decisions. Clinical care is provided by independent licensed physicians.

The service offers a $99 one time laboratory and physician review option, a $149 monthly plan and a $349 monthly plan with expanded testing and a care navigator. Medication costs are separate. Early access starts through the company's waitlist and is not available in Hawaii or Rhode Island.

We hope you enjoyed this article

Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Healthcare & Life Sciences AI AI Brief AI Brief (X)
Free newsletter

Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

AI Token Webinar

Market report

2025 Generative AI in Professional Services Report

Thomson Reuters

This report by Thomson Reuters explores the integration and impact of generative AI technologies, such as ChatGPT and Microsoft Copilot, within the professional services sector. It highlights the growing adoption of GenAI tools across industries like legal, tax, accounting, and government, and discusses the challenges and opportunities these technologies present. The report also examines professionals' perceptions of GenAI and the need for strategic integration to maximize its value.

Read more

You may also like

Free, six days a week

Daily AI Brief: the AI news that matters, in your inbox.